Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00003061 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003061 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma |
| Official title | Evaluating the MBVP Chemotherapy Schedule Followed by Consolidating Radiotherapy in Non-AIDS Related Primary Central Nervous System Lymphoma (NAPCL) |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | cytarabine, methotrexate, radiation therapy |
| Enrollment | 50 |
| Start date | Jul 1, 1997 |
| Primary completion | Mar 1, 2002 |
| First posted | Apr 14, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Belgium, France, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: